Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Search research articles

Related Experiment Videos

Novel therapies.

Douglas E Peterson¹, Susan L Beck, Dorothy M K Keefe

¹Department of Oral Diagnosis, School of Dental Medicine, University of Connecticut Health Center, Farmington 06030-1605, USA.

Seminars in Oncology Nursing

|March 25, 2004

Summary

This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Artificial intelligence model predicts malignant transformation of oral leukoplakia and optimizes interventions.

Oral oncology·2026

Same author

The 2024 International Society of Oral Oncology-Multinational Association of Supportive Care in Cancer-American Society of Clinical Oncology guidelines for the prevention and management of osteoradionecrosis of the jaw: Summary and implications for dental team members.

Journal of the American Dental Association (1939)·2025

Same author

Correction to: A systematic review of salivary gland hypofunction and/or xerostomia induced by non‑surgical cancer therapies: prevention strategies.

Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer·2025

Same author

Implementation of the 2024 ASCO guidelines for the prevention and management of osteoradionecrosis in patients with head & neck cancer treated with radiation therapy.

Current opinion in oncology·2025

Same author

Oral Immune-Related Adverse Events Secondary to Immune Checkpoint Inhibitors: Call to Action.

JCO oncology practice·2025

Same author

International Expert-Based Consensus Definition, Classification Criteria, and Minimum Data Elements for Osteoradionecrosis of the Jaw: An Interdisciplinary Modified Delphi Study.

International journal of radiation oncology, biology, physics·2025

Same journal

Boundary Erosion in Oncology Nursing: Psychosocial Consequences and Coping Strategies-A Qualitative Study.

Seminars in oncology nursing·2026

Same journal

Health-Related Quality of Life in Cancer Cachexia: Validation of the Turkish Version of the Functional Assessment of Anorexia/Cachexia Therapy (FAACT).

Seminars in oncology nursing·2026

Same journal

A Dyadic Study of Lived Experiences of Family Stress, Emotional Distress and Family Resilience Among Women With Cancer During Pregnancy and Their Partners.

Seminars in oncology nursing·2026

Same journal

Rapid Reduction in Cancer Worry Through a Mindfulness-based Coping Programme: Evidence from a Randomised Trial with Women Awaiting Biopsy Results.

Seminars in oncology nursing·2026

Same journal

Refining Genomic Integration in Hereditary Breast Cancer: Reflections on Clinical and Nursing Implications.

Seminars in oncology nursing·2026

Same journal

Bridge Symptoms Between Symptom Clusters in Children with Acute Lymphoblastic Leukemia During Maintenance Therapy: A Network Analysis.

Seminars in oncology nursing·2026

See all related articles

New drug and device technologies show promise for managing cancer patient mucositis. Future research will explore multi-agent therapies, with oncology nurses crucial for patient care.

Area of Science:

Oncology
Pharmacology
Biotechnology

Background:

Mucositis is a debilitating side effect of cancer treatment.
Current management strategies for mucositis have limitations.
Advances in understanding mucosal injury offer new therapeutic avenues.

Purpose of the Study:

To review emerging drug and device technologies for managing cancer patient mucositis.
To assess the potential impact of novel mucositis therapies.
To highlight the role of molecular modeling in developing new treatments.

Main Methods:

Review of published research articles and abstracts.
Inclusion of clinical experience.
Focus on molecular modeling of mucosal injury.

Related Experiment Videos

Main Results:

Single-agent interventions are being investigated with varying efficacy.
Molecular modeling advances are creating new therapeutic opportunities.
Research indicates a need for further investigation into optimal dosing.

Conclusions:

Novel drug and device technologies hold promise for improved mucositis management.
Development of multi-agent therapies is a future direction.
Oncology nurses are essential in assessing and managing mucositis.